These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 7178700)

  • 1. [Effects of disopyramide phosphate in repetitive paroxysmal ventricular tachycardia].
    Katoh T; Sasaki Y; Tsuda T
    Kokyu To Junkan; 1982 Sep; 30(9):959-64. PubMed ID: 7178700
    [No Abstract]   [Full Text] [Related]  

  • 2. [Antiarrhythmic actions of disopyramide phosphate in patients with paroxysmal supraventricular tachycardia (author's transl)].
    Satoh M; Sada T; Kuan-Min S; Kira Y; Sekine I; Okabe F; Ueda A; Ito T; Matsumoto S
    Kokyu To Junkan; 1981 May; 29(5):537-44. PubMed ID: 7313358
    [No Abstract]   [Full Text] [Related]  

  • 3. [Effect of intravenous disopyramide in supraventricular paroxysmal tachycardia refractory to vagal maneuvers].
    Romero-Ayala LC; Soní J
    Arch Inst Cardiol Mex; 1983; 53(2):147-51. PubMed ID: 6882095
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Prevention and therapy of supraventricular paroxysmal tachycardia in ambulatory patients. Results of a multicentric study using disopyramide].
    Rouhi A; Penth B; Adams HJ
    Ther Ggw; 1979 Jun; 118(6):957-69. PubMed ID: 462395
    [No Abstract]   [Full Text] [Related]  

  • 5. The effect of intravenous disopyramide phosphate on recurrent paroxysmal tachycardias.
    Camm J; Ward D; Spurrell RA
    Br J Clin Pharmacol; 1979 Nov; 8(5):441-9. PubMed ID: 508548
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Disopyramide in pregnancy: a case report.
    Shaxted EJ; Milton PJ
    Curr Med Res Opin; 1979; 6(1):70-2. PubMed ID: 456013
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intravenous disopyramide phosphate and ventricular overdrive pacing in the termination of paroxysmal ventricular tachycardia.
    Camm J; Ward D; Washington HG; Spurrell RA
    Pacing Clin Electrophysiol; 1979 Jul; 2(4):395-402. PubMed ID: 95308
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical evaluation of antiarrhythmic effects of disopyramide by multiclinical controlled double-blind methods.
    Kimura E; Mashima S; Tanaka T
    Int J Clin Pharmacol Ther Toxicol; 1980; 18(8):338-43. PubMed ID: 7409935
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Action of injectable disopyramide phosphate in the emergency treatment of ventricular tachycardia].
    Valère PE; Guerot C; Castillo Fenoy A; Branvin E; Urbanczyk A; Tricot R
    Coeur Med Interne; 1977; 16(2):285-92. PubMed ID: 891126
    [No Abstract]   [Full Text] [Related]  

  • 10. A double-blind trial of disopyramide, procaineamide and digoxin in paroxysmal suptraventricular tachycardia.
    Millar-Craig MW; Raftery EB
    Clin Cardiol; 1979 Jun; 2(3):179-84. PubMed ID: 389512
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Clinical evaluation of Rhytmodan in heart rhythm disorders].
    Dzieglielewski T; Wachowiak A
    Pol Tyg Lek; 1973 Dec; 28(52):2065-7. PubMed ID: 4769022
    [No Abstract]   [Full Text] [Related]  

  • 12. [Therapy of ventricular tachyarrhythmia with disopyramid phosphate].
    Steinbrunn W; Mattmann H; Enrico JF; Engel U
    Schweiz Med Wochenschr; 1980 Jun; 110(24):953-7. PubMed ID: 7414314
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [On the clinical trial of disopyramide (Rhythmodan) in the prevention of attacks of supraventricular paroxysmal tachycardia].
    Masini G
    Minerva Med; 1970 Sep; 61(71 Suppl):3748-52. PubMed ID: 5454440
    [No Abstract]   [Full Text] [Related]  

  • 14. [Effects of intravenous disopyramide on induction and termination of paroxysmal supraventricular tachycardia via an accessory pathway].
    Komatsu C; Ishinaga T; Tateishi O; Tokuhisa Y; Hara M; Sanada T; Kanae K; Satoh Y; Yoshimura S
    Kokyu To Junkan; 1984 Apr; 32(4):409-14. PubMed ID: 6463419
    [No Abstract]   [Full Text] [Related]  

  • 15. Effects of oral disopyramide phosphate on induction of paroxysmal supraventricular tachycardia.
    Swiryn S; Bauernfeind RA; Wyndham CR; Dhingra RC; Palileo E; Strasberg B; Rosen KM
    Circulation; 1981 Jul; 64(1):169-75. PubMed ID: 7237716
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Induction and termination of ventricular tachycardia by programmed electrical stimulation of heart--a case in which the effect of disopyramide phosphate was confirmed by the stimulation study (author's transl)].
    Komatsu C; Ishinaga T; Motoyama M; Marutani K; Teruya H; Nakayama M; Kuno A; Sato Y; Yoshimura S
    Kokyu To Junkan; 1981 Feb; 29(2):209-15. PubMed ID: 6789431
    [No Abstract]   [Full Text] [Related]  

  • 17. Mental distress in patient on disopyramide.
    Falk RH; Nisbet PA; Gray TJ
    Lancet; 1977 Apr; 1(8016):858-9. PubMed ID: 67366
    [No Abstract]   [Full Text] [Related]  

  • 18. Serendipitous relief with disopyramide of phobia for flying.
    Lewis DO
    Am J Psychiatry; 1983 Oct; 140(10):1387. PubMed ID: 6624986
    [No Abstract]   [Full Text] [Related]  

  • 19. [Effectiveness and mechanism of the anti-arrhythmic action of ritmilen in patients with paroxysms of atrioventricular node reciprocal tachycardia].
    Grosu AA
    Biull Vsesoiuznogo Kardiol Nauchn Tsentra AMN SSSR; 1984; 7(2):98-9. PubMed ID: 6508939
    [No Abstract]   [Full Text] [Related]  

  • 20. Efficacy of disopyramide phosphate in the treatment of refractory ventricular arrhythmias.
    Meyers DG; Mohiuddin SM
    Nebr Med J; 1980 May; 65(5):123-5. PubMed ID: 7383223
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.